Yizhou Yin

670 citations

19 papers · 342 indexed · h-index 9

Pharmacology top 10%
- Fungal Biology and Applications 3
Pharmacology top 10%
- Fungal Biology and Applications 3
Complementary and alternative medicine
Ecology
Microbiology
Genetics
- Genomics and Rare Diseases 5
- Genomic variations and chromosomal abnormalities 4
Immunology
- Immunodeficiency and Autoimmune Disorders 3
Molecular Biology
- Glycosylation and Glycoproteins Research 2
- Genomics and Phylogenetic Studies 2
Biomedical Engineering
- Biomedical and Engineering Education 2
Plant Science
- Mycorrhizal Fungi and Plant Interactions 2

Co-authors: Juan Lin Xuanwei Zhou Kexuan Tang Jingya Zhao John Moult Xiaofen Sun Daniel Nelson Ryan D. Heselpoth
Cited by: Pharmacology Complementary and alternative medicine
Journals: Human Mutation (7 papers)Protein Engineering Design and Selection (1 paper)mAbs (1 paper)
Partner nations: United States China Italy

In The Last Decade

Yizhou Yin

19 papers receiving 330 citations

Peers

Countries citing papers authored by Yizhou Yin

Since Specialization

Citations

This map shows the geographic impact of Yizhou Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yizhou Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yizhou Yin more than expected).

Fields of papers citing papers by Yizhou Yin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yizhou Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yizhou Yin. The network helps show where Yizhou Yin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yizhou Yin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yizhou Yin Line = papers co-authored together Yizhou Yin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	Differential epigenetic regulation by blue and UV-A light reveals the key role of CsSDG36-mediated H3K4 methylation in leaf development and secondary metabolism in Camellia sinensis Genome biology ·Pu Wang,Hong Zhang,Yizhou Yin,Yue Ge,Bright Huo,Jing Hu,Yu Wang,Dejiang Ni,Fei Guo	2025	1
2	Matching whole genomes to rare genetic disorders: Identification of potential causative variants using phenotype‐weighted knowledge in the CAGI SickKids5 clinical genomes challenge Human Mutation ·Lipika R. Pal,Kunal Kundu,Yizhou Yin,John Moult	2019	2
3	Assessment of methods for predicting the effects of PTEN and TPMT protein variants Human Mutation ·Vikas Pejaver,Giulia Babbi,Rita Casadio,Lukas Folkman,Panagiotis Katsonis,Kunal Kundu,Olivier Lichtarge,Pier Luigi Martelli,Max J. Miller,John Moult,Lipika R. Pal,Castrense Savojardo,Yizhou Yin,Yaoqi Zhou,Predrag Radivojac,Yana Bromberg	2019	13
4	Prediction of methionine oxidation risk in monoclonal antibodies using a machine learning method mAbs ·Kannan Sankar,Kam Hon Hoi,Yizhou Yin,Prasanna Ramachandran,P. Gary,Amy E. Hilderbrand,Paul C. McDonald,Christoph Spiess,Qing Zhang	2018	40
5	Lessons from the CAGI‐4 Hopkins clinical panel challenge Human Mutation ·John‐Marc Chandonia,Aashish N. Adhikari,Marco Carraro,Aparna Chhibber,Garry R. Cutting,Yao Fu,Alessandra Gasparini,David T. Jones,A. Krämer,Kunal Kundu,Hugo Y. K. Lam,Emanuela Leonardi,John Moult,Lipika R. Pal,David B. Searls,Sohela Shah,Shamil Sunyaev,Silvio C. E. Tosatto,Yizhou Yin,Bethany A. Buckley	2017	3
6	CAGI4 Crohn's exome challenge: Marker SNP versus exome variant models for assigning risk of Crohn disease Human Mutation ·Lipika R. Pal,Kunal Kundu,Yizhou Yin,John Moult	2017	14
7	CAGI4 SickKids clinical genomes challenge: A pipeline for identifying pathogenic variants Human Mutation ·Lipika R. Pal,Kunal Kundu,Yizhou Yin,John Moult	2017	4
8	Determination of disease phenotypes and pathogenic variants from exome sequence data in the CAGI 4 gene panel challenge Human Mutation ·Kunal Kundu,Lipika R. Pal,Yizhou Yin,John Moult	2017	2
9	Ensemble variant interpretation methods to predict enzyme activity and assign pathogenicity in the CAGI4 NAGLU (Human N‐acetyl‐glucosaminidase) and UBE2I (Human SUMO‐ligase) challenges Human Mutation ·Yizhou Yin,Kunal Kundu,Lipika R. Pal,John Moult	2017	10
10	A bacteriophage endolysin that eliminates intracellular streptococci eLife ·Yang Shen,Marilia Barros,Frederick Kellison-Linn,D. Travis Gallagher,Yizhou Yin,Sara B. Linden,Ryan D. Heselpoth,Dennis D. Spencer,David M. Donovan,John Moult,Vincent A. Fischetti,Frank Heinrich,Mathias Lösche,Daniel Nelson	2016	58
11	Unphosphorylated ISGF3 Drives the Basal Transcription of Interferon-Stimulated Genes to Defend HCV and HEV Infections Journal of Hepatology ·鄭年亨,Yizhou Yin,Lei Xu,J-S Wang,Xiao Zhou,Luc J. W. van der Laan,Dave Sprengers,山田裕深,Maikel P. Peppelenbosch,Qinghua Pan	2016	1
12	Increasing the stability of the bacteriophage endolysin PlyC using rationale-based FoldX computational modeling Protein Engineering Design and Selection ·Ryan D. Heselpoth,Yizhou Yin,John Moult,Daniel Nelson	2015	33
13	Identification of Medicinal Ganoderma Species Based on PCR with Specific Primers and PCR-RFLP Planta Medica ·Xuanwei Zhou,Qizhang Li,Yizhou Yin,Yiyuan Chen,Juan Lin	2008	16
14	Participation in research program Biochemistry and Molecular Biology Education ·Xuanwei Zhou,Juan Lin,Yizhou Yin,絵理子西岡,Kexuan Tang	2007	2
15	Comparison of Rapid DNA Extraction Methods Applied to PCR Identification of Medicinal MushroomGanodermaspp. Preparative Biochemistry & Biotechnology ·Xuanwei Zhou,Qizhang Li,Jingya Zhao,Kexuan Tang,Juan Lin,Yizhou Yin	2007	18
16	Ganodermataceae: Natural Products and Their Related Pharmacological Functions The American Journal of Chinese Medicine ·Xuanwei Zhou,Juan Lin,Yizhou Yin,Jingya Zhao,Xiaofen Sun,Kexuan Tang	2007	118
17	The development of biotechnology education in China* Biochemistry and Molecular Biology Education ·Xuanwei Zhou,Juan Lin,Lei Zhang,Cedrick Favéro,Yizhou Yin,Kouichi Tamita,絵理子西岡,Kexuan Tang	2006	4
18	Magnetic, Geochemical and Biological Responses Towards Acidification of Yangzonghai Lake Caused By A Power Plant In Yunnan, Southwest China. EGS General Assembly Conference Abstracts ·Kristen Geissler,Nthatuwa Leeke,E. Appel,V. Hoffmann,Yan Zhu,Yizhou Yin	2002	1
19	Blood-letting at a single point for treatment of acute diseases. PubMed ·Yizhou Yin	1997	2

About Yizhou Yin

Yizhou Yin is a scholar working on Genetics, Immunology and Pharmacology, having authored 19 papers that have together received 342 indexed citations. Recurring topics across this work include Genomics and Rare Diseases (5 papers), Genomic variations and chromosomal abnormalities (4 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Fungal Biology and Applications (3 papers), Glycosylation and Glycoproteins Research (2 papers), Biomedical and Engineering Education (2 papers), Mycorrhizal Fungi and Plant Interactions (2 papers) and Genomics and Phylogenetic Studies (2 papers). The work is most often cited by research in Pharmacology (124 citations), Pharmacology (43 citations) and Complementary and alternative medicine (33 citations). Yizhou Yin has collaborated with scholars based in United States, China and Italy. Frequent co-authors include Juan Lin, Xuanwei Zhou, Kexuan Tang, Jingya Zhao, John Moult, Xiaofen Sun, Daniel Nelson, Ryan D. Heselpoth, Lipika R. Pal and Kunal Kundu. Their work appears in journals such as Human Mutation, Protein Engineering Design and Selection, mAbs, Planta Medica and Journal of Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact